Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Lumbar WBCT vs MRI

10. November 2026 aktualisiert von: Neil Segal, MD, MS, University of Kansas Medical Center

Standing Weight-Bearing Cone-Beam CT and Clinical Phenotype Concordance in Lumbar Degenerative Radiculopathy

Patients with pain in their low back that sometimes sends a shooting, sharp pain down their leg are usually diagnosed with lumbar radicular pain, or lumbar radiculopathy. MRIs are most commonly used to acquire images of the spine. The purpose of these images is to provide doctors with important information on what may be causing the low back pain and what treatment options may be the most effective in treating the pain. However, standard MRIs are taken when the patient is lying down, which may not be the most accurate representation of what the spine looks like in positions where patients experience pain, such as standing. A weight-bearing CT (WBCT) scan is a 3D imaging test that takes detailed pictures of the spine while patients are standing up. Unlike traditional MRI scans, where the patient lies down, this technology provides more information on how the spine looks when the patient is upright and participating in activities such as standing and walking. This information allows doctors to better understand the underlying causes of the pain and help guide targeted treatments to address those issues.

The Planmed XFI full-body weight-bearing CT scanner received 510(k) clearance from the FDA on September 26, 2025. This means the Planmed XFI® WBCT is safe and effective because it is substantially equivalent to a device already on the market.

Studienübersicht

Status

Noch keine Rekrutierung

Intervention / Behandlung

Detaillierte Beschreibung

Lumbar radicular pain and radiculopathy arise from heterogeneous mechanical and inflammatory processes affecting the lumbar nerve roots. Accurate localization of the symptomatic root determines the target of interventional and surgical treatment, and incorrect localization is a plausible contributor to procedural non-response. MRI is the principal imaging examination for suspected radiculopathy because it depicts the discs, nerve roots, and perineural fat. Its agreement with the clinically symptomatic root, however, is moderate at best. For the present study, a prospectively standardized, blinded, pre-imaging clinical phenotype serves as the operational reference standard. It is performed in every participant before any study imaging, locked before acquisition, and not revised afterward, so that imaging is scored against a fixed clinical target rather than reconciled with it. Across loaded and upright studies, mean positional effects on foraminal dimension are small and directionally mixed, and the literature is heterogeneous in device, posture, loading method, and outcome measure. Standing weight-bearing cone-beam CT provides three-dimensional isotropic imaging of the osseous foraminal boundary under physiological load, permitting quantitative cross-sectional area measurement in neutral and extension within a single session. Soft-tissue contrast is limited relative to MRI, which is why all primary measurements in this protocol are bony-boundary geometric measures. To our knowledge, no previous study has evaluated standing lumbar weight-bearing CT against a prospectively standardized, blinded, pre-imaging clinical phenotype. This study estimates that concordance, estimates whether it differs between neutral and standing extension, and characterizes the magnitude of positional change in foraminal dimension.

Studientyp

Beobachtungs

Einschreibung (Geschätzt)

90

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

  • Name: Jessica Lee, PhD
  • Telefonnummer: 913-574-0958
  • E-Mail: jlee33@kumc.edu

Studienorte

    • Kansas
      • Kansas City, Kansas, Vereinigte Staaten, 66160
        • University of Kansas Medical Center
        • Kontakt:
        • Hauptermittler:
          • Neil Segal, MD,MS

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

45 Jahre und älter (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Probenahmeverfahren

Nicht-Wahrscheinlichkeitsprobe

Studienpopulation

Adults with lumbar radicular symptoms (unilateral or bilateral with clear unilateral dominance) identified from PM&R spine clinic and affiliated clinics at KUMC.

Beschreibung

Inclusion Criteria:

  • Age ≥45 years.
  • Predominant unilateral lumbar radicular pain and/or paresthesias. True bilateral radicular presentations are excluded.
  • Lumbar radicular pattern on chart-review screening - a coarse eligibility filter only. Root level is not assigned at screening; it is assigned by the blinded standardized examination after enrollment (§8).
  • Ability to stand unsupported to undergo study examination and WBCT.
  • Informed consent, including broad re-contact consent and consent to outcomes follow-up.

Exclusion Criteria:

A candidate meeting any of the following is excluded:

  1. True bilateral or symmetric radicular presentation with no dominant symptomatic side. The side-contrast endpoint (§10.3) requires an asymptomatic homolog. Unilaterally dominant presentations with minor contralateral involvement are eligible; isolated laterality is recorded and drives a clean-unilateral sensitivity analysis.
  2. Radicular symptoms attributable to a non-degenerative cause - neoplasm, infection, inflammatory or autoimmune disease, acute fracture, or other non-degenerative structural lesion at the symptomatic level.
  3. Any prior lumbar spine surgery - instrumented fusion, posterior instrumentation, decompression, or discectomy. Altered biomechanics, junctional change, and retained/residual disc or epidural fibrosis distort foraminal and segmental anatomy and confound both measurement and symptom attribution.
  4. Any lumbar spine procedure in the last 12 weeks - including any epidural steroid injection, radiofrequency nerve ablation, facet injection, medial branch block or SI joint injection
  5. Inability to stand and hold the neutral and extension positions for acquisition with no more than light bilateral fingertip contact - from a balance disorder, orthostatic intolerance, lower-limb weakness, weight-bearing restriction, or pain that precludes positioning.
  6. Pregnancy or possibility of pregnancy. Screening and testing per institutional and RSO policy (§13).
  7. BMI > 35 kg/m2. Cone-beam image quality degrades with soft-tissue path length independently of dose, and osseous depiction becomes diagnostically unusable in the 32-35 range (Benz 2018). Because the primary endpoint is a bony-boundary geometric measurement, quality loss translates directly into measurement error. Set pre-emptively rather than by post-acquisition exclusion, which would irradiate participants whose acquisitions are predictably unusable.
  8. Inability to provide informed consent, or insufficient capacity to understand and communicate symptoms for the standardized phenotype examination (§8).

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Beobachtungsmodelle: OTHER
  • Zeitperspektiven: CROSS_SECTIONAL

Kohorten und Interventionen

Gruppe / Kohorte
Intervention / Behandlung
Lumbar WBCT

Participants will be identified through chart-review screening. Eligible and enrolled participants will undergo a blinded, standardized clinical phenotype exam performed by an evaluator blinded to the chart-review call. The participant also will be asked to complete 4 participant-reported surveys (Oswestry Disability Index (ODI), pain numeric rating scale (NRS), patient-reported provocative posture, symptom duration). The participant then will undergo two WBCT scans, one in a neutral position and one in an extension position. These two scans will be performed in the same session.

Participants will undergo two WBCT scans, one in a neutral position and one in an extension position.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Comparison of neutral WBCT position to prespecified clinical phenotype
Zeitfenster: From enrollment to end of visit at 1 day

Estimate the proportion of participants in whom neutral standing WBCT demonstrates prespecified foraminal pathology at the side and root level assigned by the blinded, locked clinical phenotype

From enrollment to end of visit at 1 day

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Comparison of extension WBCT position to prespecified clinical phenotype
Zeitfenster: From enrollment to end of visit at 1 day

Extension secondary. Estimate the proportion of participants in whom spinal extension standing WBCT demonstrates prespecified foraminal pathology at the side and root level assigned by the blinded, locked clinical phenotype; to estimate the within-participant change in concordance between the neutral and extension acquisitions; and to estimate the within-participant side-contrast on each acquisition and its change between them.

From enrollment to end of visit at 1 day
Comparison of standing WBCT to supine MRI images
Zeitfenster: From enrollment to end of visit at 1 day

MRI secondary. In the MRI-available subset, compare standing WBCT and supine MRI concordance against the same clinical reference standard (paired; McNemar on discordant pairs).

From enrollment to end of visit at 1 day
Comparison of electrodiagnostic (EDX) testing in WBCT vs MRI
Zeitfenster: From enrollment to end of visit at 1 day

EDX secondary. In the EDX-available and EDX-positive subset, describe WBCT-EDX and MRI-EDX same-level same-side agreement.

From enrollment to end of visit at 1 day

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Ermittler

  • Hauptermittler: Neil Segal, MD,MS, University of Kansas Medical Center

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Allgemeine Veröffentlichungen

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Geschätzt)

1. November 2026

Primärer Abschluss (Geschätzt)

1. November 2027

Studienabschluss (Geschätzt)

1. November 2027

Studienanmeldedaten

Zuerst eingereicht

10. November 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

10. November 2026

Zuerst gepostet (Tatsächlich)

17. November 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

17. November 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

10. November 2026

Zuletzt verifiziert

1. November 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

UNENTSCHIEDEN

Beschreibung des IPD-Plans

If deidentified IPD is requested, for example for a meta-analysis or other study requiring those data, the investigators would provide those data.

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Produkt, das in den USA hergestellt und aus den USA exportiert wird

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren